When a company announces revenue guidance that doesn't meet market expectations, it often leads to a decrease in stock price as investors adjust their expectations for future profitability. Guardant Health's announcement of a lower-than-expected revenue guidance for 2024 directly impacts investor sentiment and could lead to a short-term decrease in its stock price.